Royalty Pharma Plc (RPRX)
53.38
+0.13
(+0.24%)
USD |
NASDAQ |
May 14, 16:00
53.25
-0.13
(-0.24%)
After-Hours: 20:00
Royalty Pharma Shareholders Equity (Quarterly) : 6.889B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.19B |
| Zymeworks, Inc. | 163.59M |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Veru, Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.82B |
| Total Liabilities (Quarterly) | 9.879B |
| Debt to Equity Ratio | 1.300 |
| Current Ratio | 2.662 |
| Net Debt Paydown Yield | -1.26% |